Shree Krishna Enterprises

• Artesunate should be taken with food or drinks enriched with fat such as milk.
• Do not skip any doses and finish the full course of treatment even if you feel better.
• It may cause dizziness and sleepiness. Use caution while driving or doing anything that requires concentration.
• Do not take this medicine if you are in the first 3 months of pregnancy. Inform your doctor if you are breastfeeding.
• Inform your doctor if you notice flu-like symptoms such as chills, fever, muscle pains and any changes in a heartbeat.
• You may be asked for a regular blood test once a week while taking this medicine.

Artesunate for Injection – Product Description

Generic Name: Artesunate
Formulation: Injectable solution
Strength: Typically 60 mg/vial

Indications:
Artesunate for Injection is indicated for the treatment of severe malaria caused by Plasmodium falciparum in adults and pediatric patients. It is used when oral therapy is not possible or when the patient requires rapid treatment due to the severity of the disease.

Mechanism of Action:
Artesunate is a water-soluble derivative of artemisinin, an anti-malarial agent. It works by interfering with the parasite's ability to detoxify heme inside the red blood cells, leading to the production of free radicals that damage the parasite's cell membranes, resulting in its destruction. This rapid killing of Plasmodium falciparum is crucial in managing severe malaria.

Dosage and Administration:

• Adult Dosage: The typical dosage is 2.4 mg/kg body weight administered intravenously or intramuscularly at 0, 12, and 24 hours after the initial dose. Subsequent doses may be continued depending on the patient's clinical condition.

• Pediatric Dosage: Dosing in children is based on weight and should be administered according to a prescribed protocol.

Artesunate for Injection is usually followed by a complete oral anti-malarial regimen once the patient is able to tolerate oral medications and their condition stabilizes.

Administration Guidelines:

• The injection must be diluted and administered by a healthcare professional.

• It can be administered either intravenously (IV) or intramuscularly (IM) depending on the patient's clinical status and available resources.

• Intravenous administration is preferred in patients with severe malaria.

• Care must be taken to monitor for any adverse reactions during and after administration.

Contraindications:
Artesunate for Injection is contraindicated in patients with a known hypersensitivity to artesunate or any of its components. It should be used with caution in pregnant and breastfeeding women, although it may be administered during pregnancy when the benefit outweighs the risk.

Warnings and Precautions:

• Hypersensitivity Reactions: Monitor for signs of an allergic reaction, which may include rash, itching, or difficulty breathing.

• Hemolysis: In patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, artesunate may cause hemolysis.

• Monitoring: Regular monitoring of blood counts, liver function, and renal function is recommended during treatment.

Adverse Effects:
Common side effects may include fever, chills, dizziness, nausea, and abdominal pain. Severe adverse effects may include anaphylaxis, hemolysis, or cardiac arrhythmias.

Storage:
Store at room temperature (20–25°C) in a dry place, away from direct light. Do not freeze. Keep out of reach of children.

Conclusion:
Artesunate for Injection is a critical treatment option for severe malaria and is widely recognized for its fast action and effectiveness in treating Plasmodium falciparum infections. It is a life-saving drug when used in accordance with proper medical guidelines and under the supervision of healthcare professionals.